Evidence map›Paper›PMID 27217330›Full record

ArticleScientific reports2016

Mice lacking Programmed cell death-1 show a role for CD8(+) T cells in long-term immunity against blood-stage malaria.

Joshua M Horne-Debets, Deshapriya S Karunarathne, Rebecca J Faleiro, Chek Meng Poh, Laurent Renia, Michelle N Wykes

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Vaccines · 2021
    Review
  6. Review
  7. PD-1 blockade exacerbatesScience immunology · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Immune checkpoint blockade in infectious diseases.Nature reviews. Immunology · 2018
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Joshua M Horne-DebetsThe QIMR Berghofer Medical Research Institute, Infectious Disease Programme, Queensland, 4029, Australia.
Deshapriya S KarunarathneThe QIMR Berghofer Medical Research Institute, Infectious Disease Programme, Queensland, 4029, Australia.
Rebecca J FaleiroThe QIMR Berghofer Medical Research Institute, Infectious Disease Programme, Queensland, 4029, Australia.
Chek Meng PohSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), 136648, Singapore.
Laurent ReniaSingapore Immunology Network, Agency for Science, Technology and Research (A*STAR), 136648, Singapore.
Michelle N WykesThe QIMR Berghofer Medical Research Institute, Infectious Disease Programme, Queensland, 4029, Australia.
QIMR Berghofer Medical Research Institute · AUAgency for Science, Technology and Research · SGSingapore Immunology Network · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Even after years of experiencing malaria, caused by infection with Plasmodium species, individuals still have incomplete immunity and develop low-density parasitemia on re-infection. Previous studies using the P. chabaudi (Pch) mouse model to understand the reason for chronic malaria, found that mice with a deletion of programmed cell death-1 (PD-1KO) generate sterile immunity unlike wild type (WT) mice. Here we investigated if the mechanism underlying this defect during acute immunity also impacts on long-term immunity. We infected WT and PD-1KO mice with Pch-malaria and measured protection as well as immune responses against re-infections, 15 or 20 weeks after the original infection had cleared. WT mice showed approximately 1% parasitemia compared to sterile immunity in PD-1KO mice on re-infection. An examination of the mechanisms of immunity behind this long-term protection in PD-1KO mice showed a key role for parasite-specific CD8(+) T cells even when CD4(+) T cells and B cells responded to re-infection. These studies indicate that long-term CD8(+) T cell-meditated protection requires consideration for future malaria vaccine design, as part of a multi-cell type response.

Indexed as

AnimalsCD8-Positive T-LymphocytesDisease Models, AnimalMalariaMice, Inbred C57BLMice, KnockoutPlasmodium chabaudiProgrammed Cell Death 1 ReceptorPdcd1 protein, mouseProgrammed Cell Death 1 Receptor

Identifiers

PMID27217330
PMCPMC4877649
OpenAlexW2397394861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.